The following is a summary of the Certara, Inc. (CERT) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Certara reported Q1 2024 total revenue of $96.7 million, a reported growth of 7% and 6% in constant currency.

• Software revenue was $39.3 million, indicating 19% reported growth and 18% in constant currency.

• The technology-driven services segment reported stable year-over-year revenue at $57.3 million.

• The company recorded a net loss of $4.7 million in Q1 2024, compared to $1.4 million net income in Q1 2023.

• Adjusted EBITDA was $29.1 million for Q1 2024.

• The company anticipated its FY 2024 total revenue to range from $385 million to $400 million, with an adjusted EPS between $0.41 to $0.46 per share.

Business Progress:

• Certara introduced Certara Cloud that currently caters to 15 of the top 30 biopharmaceutical companies.

• It also planned to launch the next version of CoAuthor, an AI and machine learning-based regulatory writing tool.

• The company invested heavily in improving commercial infrastructure and expanding biosimulation software capabilities.

• The restructuring of its commercial organization and integration of AI in software offerings have positively impacted sales and marketing.

• Expectations for an increase in bookings from recently acquired companies are projected to support revenue growth for the rest of the year.

More details: Certara IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.